ICON Public Limited Company (ICLR) Stock
ICLR Key Statistics
About ICON Public Limited Company
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
CEO: Barry Balfe. Company website
ICLR — Frequently Asked Questions
What is the ICLR stock price today?
ICON Public Limited Company (ICLR) trades at $199.70, down 2.41% on the day, as of Nov 12, 2026 09:20 UTC.
What is ICON Public Limited Company's market cap?
ICON Public Limited Company has a market capitalisation of $14.96B, calculated from the live ICLR share price and shares outstanding.
What is the P/E ratio of ICLR?
ICLR trades at a trailing P/E of 34.37, from earnings per share of $5.81 over the last twelve months.
How much revenue does ICON Public Limited Company make?
ICON Public Limited Company generated revenue of $8.23B over the trailing twelve months, which puts the stock at 1.82 times sales.
What is the 52-week range for ICLR?
ICLR has traded between $66.58 and $219.04 over the past 52 weeks, and the last price is 8.8% below that high.
Is ICON Public Limited Company profitable?
Yes. ICON Public Limited Company keeps 5.45% of revenue as net income over the trailing twelve months.
What is the analyst price target for ICLR?
Wall Street analysts rate ICLR Buy, with an average price target of $217.69, 9.0% above the current price.
What sector is ICON Public Limited Company in?
ICON Public Limited Company is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in IE.
Who is the CEO of ICON Public Limited Company?
Barry Balfe is the chief executive of ICON Public Limited Company, which employs 40,200 people.
Where can I track ICLR in real time?
QFI Terminal shows ICLR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See ICLR live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ICLR in Terminal See plans